API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019774
https://www.fiercebiotech.com/biotech/genexines-weekly-growth-hormone-equal-novo-shot-phase-3-teeing-filing-china
https://endpts.com/novo-nordisk-remains-under-uk-scrutiny-as-mhra-conducts-its-own-review-in-incredibly-rare-case/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021426
https://www.fiercebiotech.com/biotech/pfizer-stumbles-close-to-finish-line-growth-hormone-race-extending-lead-rival-ascendis
https://endpts.com/pfizer-gets-some-encouraging-phiii-news-on-a-franchise-savior-but-is-a-dosing-advantage-worth-the-295m-upfront/
http://www.evaluate.com/vantage/articles/events/upcoming-events/upcoming-events-ascendis-and-lilly-hope-growth-pivotal-data?mkt_tok=eyJpIjoiTW1Jd1pqZ3lNV1JsWlRjMyIsInQiOiJZUEhaV3JnZktHSXNRdTBFYnAxNFN4NWkrelo3RmZ3eFRWZE5oZVVwOEVUWHJvZktuME1FNERjVTZqNERndTNkY2RqdFlEQ3hERE5tQTFqNXBRY2dBenp1QjVaTktlMUpQQ3lEUHdrd1N2UE1mT3hQWTNacTNSTFpsTlBQTldzYyJ9
https://endpts.com/weeks-after-launching-aeterna-zentaris-castoff-strongbridge-turns-around-and-sells-rights-to-novo-nordisk-at-a-premium/